These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 1156038)
1. Observations of the role of body fluid volumes and plasma renin activity in the management of hypertension. Dorhout Mees EJ; Geyskes GG; Vos J; Boer P Arch Int Pharmacodyn Ther; 1975 Apr; 214(2):335-46. PubMed ID: 1156038 [TBL] [Abstract][Full Text] [Related]
2. Effect of salt depletion and propranolol on blood pressure and plasma renin activity in various forms of hypertension. Geyskes GG; Boer P; Vos J; Leenen FH; Mees EJ Circ Res; 1975 Jun; 36(6 Suppl 1):248-56. PubMed ID: 1093756 [TBL] [Abstract][Full Text] [Related]
3. New concepts of the renin system and of vasoconstriction-volume mechanisms. Diagnosis and treatment of renovascular and renal hypertensions. Vaughan EF; Laragh JH Urol Clin North Am; 1975 Jun; 2(2):237-57. PubMed ID: 1098253 [TBL] [Abstract][Full Text] [Related]
4. [The hypotensive effect of propranolol: pathophysiological and clinical approach (author's transl)]. Pessina AC; Corgnati A; Palù CD G Ital Cardiol; 1976; 6(2):290-9. PubMed ID: 1010180 [TBL] [Abstract][Full Text] [Related]
5. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children]. Peco-Antić A; Nastić-Mirić D; Babić D; Kostić M Srp Arh Celok Lek; 1999; 127(9-10):305-11. PubMed ID: 10649899 [TBL] [Abstract][Full Text] [Related]
6. [Correlations between blood pressure, blood volume, plasma renin and urinary catecholamines in normal subjects and in patients with benign essential hypertension]. Weidmann P; Hirsch D; Beretta-Piccoli C; Reubi FC; Ziegler WH Schweiz Med Wochenschr; 1976 Dec; 106(49):1741-3. PubMed ID: 1013697 [TBL] [Abstract][Full Text] [Related]
7. Renin and body fluid volumes in chronic renal disease. Relations between arterial pressure, plasma renin activity, blood volume, and extracellular volume in chronic renal disease, as compared with essential hypertension. Boer P; Dorhout Mees EJ; Roos JC; Koomans HA; Geyskes GG Acta Med Scand; 1981; 210(3):207-12. PubMed ID: 7027751 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the effects on renin release of beta adrenergic antagonists with differing properties. Weber MA; Stokes GS; Gain JM J Clin Invest; 1974 Dec; 54(6):1413-9. PubMed ID: 4154950 [TBL] [Abstract][Full Text] [Related]
9. Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity. O'Malley K; Velasco M; Wells J; McNay JL J Clin Invest; 1975 Feb; 55(2):230-5. PubMed ID: 1127099 [TBL] [Abstract][Full Text] [Related]
10. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease. Jensen J; Henik RA; Brownfield M; Armstrong J Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564 [TBL] [Abstract][Full Text] [Related]
11. [Effect of diazoxide on blood pressure, PRA and plasma aldosterone in hypertensive patients (author's transl)]. Mantero F; Perini A; Armanini D; Gion M; Opocher G; Boscaro M G Ital Cardiol; 1976; 6(7):1246-53. PubMed ID: 1010235 [TBL] [Abstract][Full Text] [Related]
12. Effects of propranolol in chronic two-kidney Goldblatt hypertension in rats. Gulati OP; Liard JF Arch Int Pharmacodyn Ther; 1979 Aug; 240(2):285-93. PubMed ID: 508010 [TBL] [Abstract][Full Text] [Related]
13. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside]. Beretta-Piccoli C; Weidmann P; de Châtel R; Hirsch D; Reubi FC Schweiz Med Wochenschr; 1977 Jan; 107(4):104-15. PubMed ID: 834983 [TBL] [Abstract][Full Text] [Related]
14. The impaired control of plasma renin activity in hypertensive patients with end-stage renal disease due to chronic glomerulonephritis. Yasuda G; Nagasawa T; Umemura S; Shionoiri H; Ishii M Clin Nephrol; 1994 Nov; 42(5):300-8. PubMed ID: 7851031 [TBL] [Abstract][Full Text] [Related]
15. [The blood pressure-regulating role of the renin-angiotensin system in essential hypertension before and after emotional stress]. Hartrodt W; Enderlein J; Bauer E; Brosowski KH; Voigt S; Faulhaber HD Cor Vasa; 1987; 29(5):360-8. PubMed ID: 3322670 [TBL] [Abstract][Full Text] [Related]
16. Haemodynamic effects of propranolol in hypertension: a review. Tarazi RC; Dustan HP; Bravo EL Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955 [TBL] [Abstract][Full Text] [Related]
17. Catecholamines, sodium and renin in unilateral renal hypertension in man. Weidmann P; Schiffl H; Ziegler WH; Glück Z; Meier A; Keusch G Miner Electrolyte Metab; 1982 Feb; 7(2):97-112. PubMed ID: 6763143 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms involved in two-kidney renal hypertension induced by constriction of one renal artery. Freeman RH; Davis JO; Watkins BE; Lohmeier TE Circ Res; 1977 May; 40(5 Suppl 1):I29-35. PubMed ID: 870229 [TBL] [Abstract][Full Text] [Related]
19. [Behavior of blood volume and electrolytes in patients with essential hypertension with low plasmatic renin activity (PRA). Effects of treatment with propranolol]. Aguglia F; Santucci A; Cicconetti P; Federico M; Caputo V; Balsano F Boll Soc Ital Cardiol; 1978; 23(8):1340-8. PubMed ID: 398712 [No Abstract] [Full Text] [Related]
20. Renin--angiotensin antagonists and the regulation of blood pressure. Samuels AI; Miller ED; Fray JC; Haber E; Barger AC Fed Proc; 1976 Nov; 35(13):2512-20. PubMed ID: 185095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]